Pharmafile Logo
Pharmafocus logo
Advanced Search

Zhejiang

Showing 4 posts of 4 posts found.

amgen image

Amgen to open Chinese R&D centre

September 26, 2013
Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang

Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …

News
Amgen image

Amgen moves into Japanese market with Astellas deal

May 29, 2013
Sales and Marketing Amgen, Astellas, Vectibix, Zhejiang

Amgen and Astellas have announced a new collaboration that will see them launch five new medicines in Japan from 2016, …

News
Amgen image

Amgen and Zhejiang sign cancer deal

May 14, 2013
Sales and Marketing Amgen, Cancer, Zhejiang

Amgen has signed a joint venture deal with Chinese firm Zhejiang Beta Pharma to commercialise oncology drug Vectibix. The companies …

News

Pfizer closes in on $545m China generics deal

February 20, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics

Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China.  …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024